One more candidate for nerve repair
Posted: Mon Dec 11, 2023 9:17 am
Researchers led by a team at Canada’s Centre for Addiction and Mental Health (CAMH) have focused their work on a small molecule drug that targets the glutamate receptor AMPA, and results from the study show great promise in its new approach to treating MS.
https://newatlas.com/medical/ms-drug-re ... ve-damage/
https://newatlas.com/medical/ms-drug-re ... ve-damage/